| Perimenopausal study group | Normal | Hyperplasia | Cancer | Polyp | Total | X2 | P | ||||||||
| No | % | No | % | No | % | No | % | ||||||||
| Hypertension D.M Hypertension +D.M Hypothyroid | 2 1
1 1 | 40 20
20 20 | 1 0
0 0 | 100 0.0
0.0 0.0 | 0 1
1 0 | 0.0 50
50 0.0 | 0 1
0 0 | 0.0 100
0.0 0.0 | 3 3
2 1 | 3.6 3.15
1.48 0.9 | 0.3 0.36
0.68 0.82 | ||||
| Total | 5 | 1 | 2 | 1 | 9 |
|
| ||||||||
| Postmenopausal study group | Normal | Hyperplasia | Cancer | Polyp | Total | X2 | P | ||||||||
| No | % | No | % | No | % | No | % | ||||||||
| Hypertension D.M Hypertension +D.M Hepatic | 2 0
0 1 | 66.7 0.0
0.0 33.3 | 1 0
1 0 | 50 0.0
50 0.0 | 1 0
0 0 | 100 0.0
0.0 0.0 | 0 1
0 0 | 0.0 100
0.0 0.0 | 4 1
1 1 | 2.29 7.0
2.92 1.56 | 0.52 0.07
0.4 0.66 | ||||
| Total | 3 | 2 | 1 | 1 | 7 |
|
| ||||||||